Diet and amyotrophic lateral sclerosis

Epidemiology

Volumn 19, Issue 2, 2008, Pages 324-337

  Morozova, Natalia ^a   Weisskopf, Marc G ^a   McCullough, Marjorie L ^b   Munger, Kassandra L ^a   Calle, Eugenia E ^a   Thun, Michael J ^b   Ascherio, Alberto ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BEVERAGE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FLUID INTAKE; FOLLOW UP; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; DEATH CERTIFICATES; DIET; DIET SURVEYS; FEMALE; FOOD; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PUERTO RICO; RISK FACTORS; UNITED STATES;

EID: 39149097151     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181632c5d     Document Type: Article

References (35)

1. Armon C. Environmental risk factors for amyotrophic lateral sclerosis. Neuroepidemiology. 2001;20:2-6.
2. Nelson LM. Epidemiology of ALS. Clin Neurosci. 1995;3:327-331.
3. Weisskopf MG, McCullough ML, Calle EE, et al. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. 2004;160:26-33.
4. Nelson LM, McGuire V, Longstreth WT, et al. Population-based casecontrol study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000;151:156-163.
5. Nelson LM, Matkin C, Longstreth WT Jr, et al. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. Am J Epidemiol. 2000;151:164-173.
6. Milonas I. Amyotrophic lateral sclerosis: an introduction. J Neurol. 1998;245(Suppl 2):S1-S3.
7. Longnecker MP, Kamel F, Umbach DM, et al. Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2000;19:210-216.
8. Veldink JH, Kalmijn S, Groeneveld G-J, et al. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing ALS. J Neurol Neurosurg Psychiatry. 2007;78:367-371.
9. Willett W. Nutritional Epidemiology. Oxford: Oxford University Press; 1998.
10. Ascherio A, Weisskopf MG, O'Reilly EJ, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol. 2005;57:104-110.
11. Thun MJ, Calle EE, Rodriguez C, et al. Epidemiological research at the American Cancer Society. Cancer Epidemiol Biomarkers Prev. 2000;9:861-868.
12. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol. 1993;137:235-241.
13. World Health Organization. International Classification of Diseases. Ninth Revision. Manual of the International Statistical Classification of Disease, Injuries, and Causes of Death. Geneva, Switzerland: World Health Organization, 1977.
14. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. Geneva, Switzerland: World Health Organization; 1992.
15. World Health Organization. International Classification of Diseases for Oncology. 2nd ed. Geneva, Switzerland: World Health Organization; 1990.
16. Thun MJ, Calle EE, Namboodiri MM, et al. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst. 1992;84:1491-500.
17. Weisskopf MG, O'Reilly EJ, McCullough ML, et al. Prospective study of military service and mortality from ALS. Neurology. 2005;64:32-37.
18. Weisskopf MG, McCullough ML, Morozova N, et al. Prospective study of occupation and amyotrophic lateral sclerosis mortality. Am. J. Epidemiol. 2005;162:1146-1152.
19. Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol. 1997;244(Suppl 2):S3-S14.
20. Iwasaki Y, Ikeda K, Kinoshita M. Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosis. Curr Drug Targets CNS Neurol Disord. 2002;1:511-518.
21. Smith QR. Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr. 2000;130:1016-1022.
22. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease - fishing for a natural treatment. BMJ. 2004;328(7430):30-35.
23. Hampton T. Vitamin E derivative packs anticancer punch. JAMA. 2006;296:32.
24. Cookson MR, Shaw PJ. Oxidative stress and motor neurone disease. Brain Pathol. 1999;9:165-186.
25. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol. 1996;39:147-157.
26. Ferrante RJ, Browne SE, Shinobu LA, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem. 1997;69:2064-2074.
27. Koh S-H, Lee SM, Kim HY, et al. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci Lett. 2006;395:103-107.
28. Kuriyama S, Hozawa A, Ohmori K, et al. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr. 2006;83:355-361.
29. Chio A, Magnani C, Oddenino E, et al. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health. 1992;46:517-518.
30. Hoffman PM, Brody JA. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis. 1971;24:5-8.
31. Hoffman PM, Brody JA. The accuracy of mortality statistics in clinically proven amyotrophic lateral sclerosis. Trans Am Neurol Assoc. 1970;95:261-263.
32. Chio A. Mortality trends in ALS: an increasingly intricate puzzle. Lancet Neurol. 2005;4:453-454.
33. Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 2000;55:1262-1266.
34. Jokelainen M. The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients. J Neurol Sci. 1976;29:55-63.
35. Maasilta P, Jokelainen M, Loytonen M, et al. Mortality from amyotrophic lateral sclerosis in Finland, 1986-1995. Acta Neurol Scand. 2001;104:232-235.